Carbon Design Systems

Introducing Carbon Design Systems, EDA company formed to solve the system validation problem

Introducing Carbon Design Systems, EDA company formed to solve the system validation problem

September 2, 2003

Carbon Design Systems announced today that it is delivering software products that enable system validation of hardware and software in an enterprise-wide environment. For the first time, critical software - drivers, firmware, and diagnostics - runs at KHz execution speed on the 'golden' RTL hardware model with cycle and register accuracy. This enables system and customer validation to occur much earlier than traditional methods. The Company also announced that it has raised over $5 million in funding from Boston-based Flagship Ventures and Commonwealth Capital.

Selventa

Genstruct Completes $6.5 Million Series A Financing

Genstruct Completes $6.5 Million Series A Financing

September 8, 2003

CAMBRIDGE, Mass. September 8, 2003 - Genstruct, a biological-mechanism discovery company, today announced the completion of $6.5M in Series A financing co-led by A. M. Pappas and Associates (Research Triangle Park, NC) and Flagship Ventures (Cambridge, MA). These funds will be used to expand Genstruct's technical and business teams, build intellectual property around the company's enabling technology, and conduct internal discovery programs. As a result of the financing, Art Pappas, Managing Partner of A. M. Pappas and Associates, has joined Genstruct's Board of Directors.

CGI Pharmaceuticals, Inc.

Cellular Genomics wins European patent for kinase technology

Cellular Genomics wins European patent for kinase technology

September 16, 2003

Branford, Conn.-based Cellular Genomics Inc. today announced that the European Patent Office has granted the company a patent that covers general methods for discovering enzyme inhibitors, as well as methods and compositions of a class of specific inhibitors of protein kinases, a major class of drug targets.
CGI was granted a U.S. patent for the same technology in May 2002.

Zalicus

CombinatoRx CEO named Innovator of the Year

CombinatoRx CEO named Innovator of the Year

September 25, 2003

Alexis Borisy honored by Technology Review, MIT's Magazine of Innovation, at the Emerging Technologies Conference

e-Dialog, Inc.

E-Dialog acquires Whitespeed's rich media e-mail division

E-Dialog acquires Whitespeed's rich media e-mail division

September 30, 2003

Adds top creative, technology capabilities from interactive shop

LEXINGTON, MA - September 30, 2003 - e-Dialog, the precision e-mail marketing innovator, has acquired the e-mail marketing business of top interactive agency Whitespeed, based in Santa Monica, CA. The acquisition consolidates e-DialogÕs role as a comprehensive provider of cutting-edge e-mail services, and includes Whitespeed's e-mail client relationships, creative rich media capabilities and staff.

AVEO Pharmaceuticals, Inc.

GenPath Pharmaceuticals Raises $42.7 Million In Series B Funding

GenPath Pharmaceuticals Raises $42.7 Million In Series B Funding

October 1, 2003

Cambridge, Mass. - October 1, 2003 - GenPath Pharmaceuticals, Inc., a drug discovery and development company focused on the treatment of cancer and other diseases, announced today that it has raised $42.7 million in a Series B financing.

CGI Pharmaceuticals, Inc.

Cellular Genomics and Affymetrix form research collaboration to develop novel high-content drug screens

Cellular Genomics and Affymetrix form research collaboration to develop novel high-content drug screens

October 9, 2003

Branford, Conn. - October 9, 2003 - Cellular Genomics, Inc. (CGI), a chemical genetics based biopharmaceutical company, today announced that it has established a research collaboration with Affymetrix, Inc. the pioneer in creating breakthrough tools that are driving the genetic revolution. In the collaboration, CGI will use Affymetrix GeneChip(R) brand technology in conjunction with CGI's chemical genetics Analog Sensitive Kinase Allele (ASKA) technology for the development of unique high-content assays for kinase drug discovery.

Morphotek, Inc.

Morphotek announces contract manufacturing and development collaboration agreement with Baxter Healthcare Corporation

Morphotek announces contract manufacturing and development collaboration agreement with Baxter Healthcare Corporation

October 20, 2003

Exton, PA - October 20, 2003 - Morphotek Inc announced today that it has signed a Contract Manufacturing and Development Collaboration Agreement for use of its proprietary MORPHODOMA® technology for the development of high-titer cell lines for the manufacture of monoclonal antibody products and other biologics.

Flagship Ventures names former president of Wyeth Research, L. Patrick Gage, Venture Partner

Flagship Ventures names former president of Wyeth Research, L. Patrick Gage, Venture Partner

October 23, 2003

Pharmaceutical executive to focus on biopharmaceutical innovators

Selventa

Genstruct Appoints Sharan A. Pagano Vice President, Business Development & Alliances

Genstruct Appoints Sharan A. Pagano Vice President, Business Development & Alliances

October 29, 2003

Former Incyte, Proteome Executive Joins Mechanism Discovery Company

Wednesday October 29, 9:00 am ET CAMBRIDGE MA - Genstruct Inc., a biotechnology company that develops conceptual biological models to determine compound mechanisms of action and identify biomarkers for drug discovery and development, today announced the appointment of Sharan A. Pagano as Vice President, Business Development & Alliances.